A doctor who treats cancer patients has shared how he minimises his own risk of developing the disease by eating certain ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

Natera has reported the latest data from the Phase III CALGB (Alliance)/SWOG 80702 study, indicating that Signatera, a ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

Chemotherapeutic agents are often used to treat cancer. They combat tumor growth, but also have a number of undesirable side ...

Home > Press release: How chemotherapy drug sorafenib causes ...

After treating a tumor with chemotherapy and radiotherapy, cells known as senescent cells can appear. These are cells that do ...

The study is based on the analysis of human senescent cells in a specific tumor model — melanoma, which affects skin cells known as melanocytes — and, more specifically, melanocytes exposed to ...

The test employs a combination of tumour-agnostic next-generation sequencing and personalised tumour-informed droplet PCR ...

Circadian oscillation of biological processes has been described in most of the light-sensitive organisms on earth. It ...

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) Executive Director, Taofeek K.